“…These mechanisms entail the alteration of gene expression at the transcriptional level (e.g., methylation of DNA or acetylation of DNAbinding proteins), translational level (e.g., alternative splicing or stability of mRNA), or posttranslational level (e.g., protein modification such as phosphorylation). Most tumor promoters are not mutagenic (e.g., phenobarbital, phorbol esters, polybrominated biphenyls, saccharin, peroxisome proliferators, TCDD, DDT) (14), but can alter differentiation (15), inhibit apoptosis (16,17), induce various signal transduction pathways (e.g., protein kinase C, mitogen activated protein kinases) (18), and activate gene expression (19). Similar to tumor-promoting chemicals, ELF-EMF can also alter the transcription and translation of genes such as hsp70, myc, jun, and fos (20)(21)(22)(23).…”